Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-nephrotoxicity immunosuppression with ATG-Fresenius after liver transplantation in patients with pretransplant renal insufficiency
2011-000691-34Phase 3Completed
- Sponsor
- Dra Itxarone Bilbao. Servicio de CirugÃa Hepatobiliopancreatica y Trasplantes. HUVH.
- Start
- Jul 2011
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of antithymocyte globulin rabbit, tacrolimus, methylprednisolone and mycophenolate sodium in Renal Insufficiency (RI) and hepatic disease, sponsored by Dra Itxarone Bilbao. Servicio de CirugÃa Hepatobiliopancreatica y Trasplantes. HUVH. Primary endpoints: Renal function improvement and recovery and Biopsy-proven acute rejection. Started Jul 2011; status: completed.
02
Drugs
antithymocyte globulin rabbittacrolimusmethylprednisolonemycophenolate sodium
03
Conditions
Renal Insufficiency (RI)hepatic disease
Beyond the preview
Go deeper on 2011-000691-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000691-34.